Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study
Authors:
Open Access
- 20 August 2010
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Respiratory Disease
- Vol. 4 (5) , 271-278
Abstract
Background and aims: The purpose of this study was to investigate the efficacy of a synbiotic supplementation in reducing common winter diseases in children. Methods: A randomized, double-blind, placebo-controlled, multicentre study was conducted in young school-age children (3—7 years old) during a winter period. Participants were otherwise healthy children who suffered from at least three episodes of ear, nose and throat (ENT), respiratory tract or gastrointestinal illness during the previous winter. They were supplemented daily with either a synbiotic preparation (Lactobacillus helveticus R0052, Bifidobacterium infantis R0033, Bifidobacterium bifidum R0071, and fructooligosaccharide) or a matched placebo for 3 months. Over this period, all emergent health episodes of any type were recorded by parents in a diary. They were checked by investigators at regular monthly visits. The main study outcome was the percentage of children free of any episode during the study course. Results: We randomized 135 children (mean age: 4.1±1.0 years) to the synbiotic group ( n = 62) or placebo ( n = 73) group. At least one illness episode was reported in 32 children in the synbiotic group and 50 in the placebo group (51.6% versus 68.5%). This corresponded to a significant 25% relative risk reduction (95% CI 0.6—44.3%; p = 0.045). This difference was due to a decrease in the number of children who suffered from at least one ENT, respiratory tract or gastrointestinal disorder (50.0% with synbiotic versus 67.1% with placebo; p = 0.044). At least one sickness school day loss was noted in 25.8% of children with the synbiotic as compared with 42.5% with placebo ( p = 0.043). No treatment related side effects were detected in either group. Conclusions: This study suggests that a 3-month supplementation with this synbiotic preparation can decrease the risk of occurrence of common infectious diseases in children and limits the risk of school day loss.Keywords
This publication has 20 references indexed in Scilit:
- Parental Opinions about Biomedical Research in Children in Tours, FranceDevelopmental Pharmacology and Therapeutics, 2017
- Probiotic Effects on Cold and Influenza-Like Symptom Incidence and Duration in ChildrenPediatrics, 2009
- Pilot Trials in Clinical ResearchCirculation, 2009
- Long-Term Safety and Impact on Infection Rates of Postnatal Probiotic and Prebiotic (Synbiotic) Treatment: Randomized, Double-Blind, Placebo-Controlled TrialPediatrics, 2008
- Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patientsCritical Care, 2008
- Clinical Indications for Probiotics: An OverviewClinical Infectious Diseases, 2008
- Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trialVaccine, 2006
- The Role of Probiotics in the Management of Allergic DiseaseClinical & Experimental Allergy, 2006
- Probiotics and non-intestinal infectious conditionsBritish Journal of Nutrition, 2002
- Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trialBMJ, 2001